Scheithauer, W <br/><br/>
Second-line treatment with oxaliplatin + raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapy.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  May 2001 
 - 709-14 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0923-7534 
<br/><br/><label>Standard No.: </label>10.1023/a:1011194712661  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Camptothecin--analogs & derivatives<br/>Colorectal Neoplasms--drug therapy<br/>Disease Progression<br/>Disease-Free Survival<br/>Drug Resistance, Neoplasm<br/>Female<br/>Fluorouracil--pharmacology<br/>Humans<br/>Irinotecan<br/>Leucovorin--pharmacology<br/>Male<br/>Middle Aged<br/>Neutropenia--chemically induced<br/>Organoplatinum Compounds--administration & dosage<br/>Oxaliplatin<br/>Quinazolines--administration & dosage<br/>Salvage Therapy<br/>Thiophenes--administration & dosage<br/>Treatment Outcome